BackOyster Point Pharma Overview

Oyster Point Pharma Selling, General & Admin

Oyster Point Pharma selling, general & admin — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$34.24M
20.16% YoY

As of Sep 30, 2022

Annual SG&A Expenses (TTM)

$154.80M
129.6% YoY

Trailing 12 months ending Sep 30, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Oyster Point Pharma (OYST) FAQ

Stockcircle tracks selling, general & admin for Oyster Point Pharma (OYST), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Oyster Point Pharma's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main OYST overview so you can move from this figure to the surrounding analysis quickly.